CN Patent

CN108785263B — 普拉克索或其药用盐的固体药物组合物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2021-06-29 · 5y expired

What this patent protects

本发明涉及普拉克索或其药用盐的固体药物组合物及其制备方法。具体而言，本发明涉及的固体药物组合物含有普拉克索或其药用盐或其溶剂合物作为活性成分，还含有缓释骨架材料、磷酸钙盐和其他赋形剂。该固体药物组合物具有良好的溶出度和稳定性，在高温高湿条件下仍具有良好的释放行为。

USPTO Abstract

本发明涉及普拉克索或其药用盐的固体药物组合物及其制备方法。具体而言，本发明涉及的固体药物组合物含有普拉克索或其药用盐或其溶剂合物作为活性成分，还含有缓释骨架材料、磷酸钙盐和其他赋形剂。该固体药物组合物具有良好的溶出度和稳定性，在高温高湿条件下仍具有良好的释放行为。

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN108785263B
Jurisdiction: CN
Classification: —
Expires: 2021-06-29
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Hengrui Medicine Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.